Primary Job Title Co-Founder and CEO Primary Organization Glyphic Biotechnologies
Location Palo Alto, California, United States Regions San Francisco Bay Area, Silicon Valley, West Coast Gender Male Also Known As Joshua Young, Josh Yang, Josh Young, Joshua Young Yang, Josh Young Yang
Website www.joshuayang.com LinkedIn View on LinkedIn X (Twitter) View on X
Hi, I'm Josh, the co-founder and CEO of Glyphic Biotechnologies, a VC-funded biotechnology startup commercializing a next-generation protein sequencing platform. My first startup Nephrosant has raised over $22M in funding to commercialize a low-cost, non-invasive diagnostic assay for kidney injury.
I graduated Phi Beta Kappa, Tau Beta Pi, and
Summa Cum Laude from the University of California, San Diego, which I attended fully-funded on the Jacobs School Scholarship. I double majored in Bioengineering: Biotechnology B.S. and General Biology B.S where I was a Barry Goldwater Scholar and the Valedictorian in the Department of Bioengineering. Subsequently, I completed a Master of Translational Medicine degree through the University of California, San Francisco and University of California, Berkeley in the Department of Bioengineering, from where I spin-out my first startup. I am currently on leave of absence from the MSTP MD-PhD at the Johns Hopkins University School of Medicine and Department of Biomedical Engineering. I subsequently graduated with an MBA from the Stanford University Graduate School of Business, where I was the Henry Ford II Scholar (Valedictorian), a Siebel Scholar, and an Arjay Miller Scholar.
My first-author, peer-reviewed publications have been published in top-tier journals such as Nature Reviews Genetics and Science Translational Medicine. I am also an inventor on 6 issued/filed patents and author on 18 research articles. I was named to the Forbes 30 Under 30 Healthcare list in 2021.
In my free time, I enjoy going to farmer's markets on Sunday mornings, sipping on dirty chai lattes, and creating pastries from scratch.
